Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MUSE vs VRTS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VRTS Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

VRTS Overall Winner 6-Pillar Tally: MUSE 0 – 5 VRTS (1 Tie) Matrix Metrics: MUSE 2 – 8 VRTS

As of Nov 20, 2026, Virtus Investment Partners, Inc. (VRTS) is the stronger overall head-to-head candidate over MUSE (MUSE) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MUSE carries a Unified Composite Score of 45.9/100 (HOLD) at $47.67 (N/M Forward P/E, N/A operating margin), whereas VRTS carries 39.3/100 (SELL) at $101.01 (5.0x Forward P/E, 14.0% operating margin).

  • Composite vs. Pillar Nuance: While MUSE currently prints a higher short-term Unified Composite Score (45.9/100 HOLD vs. VRTS 39.3/100 SELL), VRTS captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (14.0% vs. N/A operating margin) and revenue trajectory (-8.7% vs. N/A YoY).
  • Technical & Structure Timing Caution: MUSE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 34.4); meanwhile VRTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MUSE vs VRTS
MUSE US Equity
MUSE
Institutional Equity
$47.67
-0.13% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.10β · 4% Vol
Unified Composite Score
45.9 / 100 HOLD
Tech 48.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.3%) with fading momentum, RSI 34
RSI-14: 34.4 · SMA20: $47.98 · SMA50: $48.24
VRTS NYSE Head-to-Head Winner
Virtus Investment Partners, Inc.
Investment Advice
$101.01
-4.81% 1D
Market Cap $696.1M
TTM Revenue $807M
Forward P/E 5.0x
Beta / 30D Vol 1.20β · 65% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.6%), weak momentum, RSI 30
RSI-14: 30.0 · SMA20: $121.25 · SMA50: $125.70

6-Pillar Scorecard Institutional Category Breakdown (MUSE 0 – 5 VRTS)

Columns: Metric · MUSE · VRTS
1. Valuation Multiples VRTS
Forward P/E N/M 5.0x
Trailing P/E N/M 6.6x
PEG Ratio N/M 0.56x
EV / Revenue N/M 0.9x
2. Growth & Scale VRTS
Revenue Growth (YoY) N/A -8.7%
Earnings Growth (YoY) N/A -29.9%
TTM Revenue (USD) N/A $807M
Market Cap N/A $696.1M
3. Profitability & Quality VRTS
Gross Margin N/A 40.8%
Operating Margin N/A 14.0%
Net Profit Margin N/A 13.6%
Return on Equity (ROE) N/A 9.6%
4. Balance Sheet & Cash Flow VRTS
Cash Generation (TTM) N/A $191M EBITDA
Cash Flow Margin N/A 23.7% EBITDA Mgn
Net Cash / Leverage N/A ROE $144.34 Book/Sh · 9.6% ROE
Dividend Yield None (0.00%) 8.59%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat VRTS
OpEx & R&D Intensity N/A 26.8% of Rev ($216M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MUSE (2) vs VRTS (8)
Institutional Metric MUSE VRTS Criterion Row Edge
Market Capitalization
Scale
N/A $696.1M Larger Scale VRTS
Trailing P/E Ratio
Valuation
N/M 6.6x Lower Multiple VRTS
Forward P/E Ratio
Valuation
N/M 5.0x Lower Multiple VRTS
Revenue Growth (YoY)
Growth
N/A -8.7% Higher Growth VRTS
Operating Margin (TTM)
Profitability
N/A 14.0% Higher Margin VRTS
Net Profit Margin
Profitability
N/A 13.6% Higher Margin VRTS
Return on Equity (ROE)
Capital Efficiency
N/A 9.6% Higher ROE VRTS
52-Week Range Position
Momentum
0% ($48–$52) 1% ($100–$176) Stronger Trend VRTS
Beta / 30D Volatility
Risk Regime
0.10β · 4% Vol 1.20β · 65% Vol Lower Realized Risk MUSE
Unified Institutional Score
Composite Signal
45.9 / 100 (HOLD) 39.3 / 100 (SELL) Higher Composite MUSE
Trailing 12M Revenue (USD)
Operating Scale
N/A $807M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 40.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.56x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $191M EBITDA ($144.34 Book/Sh · 9.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MUSE +16.79 pp
MUSE: -0.65% · VRTS: -17.44%
3M Horizon MUSE +36.22 pp
MUSE: -3.68% · VRTS: -39.9%
6M Horizon MUSE +20.06 pp
MUSE: -3.76% · VRTS: -23.82%
1Y Horizon MUSE +30.01 pp
MUSE: -5.32% · VRTS: -35.33%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MUSE vs VRTS. Trailing 12-month operating profitability (MUSE N/A vs VRTS 14.0%) and valuation multiples (MUSE N/M vs VRTS 5.0x Forward P/E) are benchmarked directly in Pillar 4 below.

MUSE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
VRTS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$807M
Gross Margin40.8%
Op. Margin14.0%
ROE / Fwd P/E9.6% · 5.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MUSE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MUSE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VRTS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VRTS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MUSE Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
VRTS Moat Profile Cyclical / Execution-Driven Positioning
Asset Management Operator
Competes within the Asset Management value chain with $696.1M market capitalization and 14.0% operating margin.
OpEx & R&D Reinvestment 26.8% of Rev ($216M)
90D Engineering Disclosures 0 Published

Investor FAQ MUSE vs VRTS Key Questions & Quantitative Answers

As of Nov 20, 2026, Virtus Investment Partners, Inc. (VRTS) is the stronger overall head-to-head candidate over MUSE (MUSE) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MUSE carries a Unified Composite Score of 45.9/100 (HOLD) at $47.67 (N/M Forward P/E, N/A operating margin), whereas VRTS carries 39.3/100 (SELL) at $101.01 (5.0x Forward P/E, 14.0% operating margin). Composite vs. Pillar Nuance: While MUSE currently prints a higher short-term Unified Composite Score (45.9/100 HOLD vs. VRTS 39.3/100 SELL), VRTS captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (14.0% vs. N/A operating margin) and revenue trajectory (-8.7% vs. N/A YoY). Technical & Structure Timing Caution: MUSE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 34.4); meanwhile VRTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VRTS leads the Growth & Scale pillar: MUSE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with VRTS at -8.7% YoY revenue growth and -29.9% YoY earnings growth on $807M TTM revenue (40.8% gross margin, 14.0% operating margin). On trailing 12-month operating scale, MUSE generates N/A in USD-normalized revenue versus $807M for VRTS. In operating R&D and SG&A reinvestment, MUSE deploys N/A (0 90-day corporate R&D disclosures) versus 26.8% of Rev ($216M) (0 disclosures) for VRTS.

VRTS screens cheaper on headline valuation multiples. MUSE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas VRTS trades at 5.0x Forward P/E, 6.6x Trailing P/E, 0.56x PEG, and 0.9x EV/Revenue (23.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MUSE (N/A ROE) versus VRTS (9.6% ROE) capital efficiency.

In options market volatility and institutional positioning, MUSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.10β · 4% Vol realized risk). By comparison, VRTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.20β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.